Vogelzang, E H <br/><br/>
Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.  [electronic resource] 

 -  Annals of the rheumatic diseases  Feb 2015 
 - 474-5 p.  digital 
<br/><br/> Publication Type: Letter; Observational Study 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2014-206588  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Psoriatic--blood<br/>Arthritis, Rheumatoid--blood<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Humans<br/>Middle Aged